Cargando…
Urine S100 proteins as potential biomarkers of lupus nephritis activity
BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655804/ https://www.ncbi.nlm.nih.gov/pubmed/29065913 http://dx.doi.org/10.1186/s13075-017-1444-4 |
_version_ | 1783273606002769920 |
---|---|
author | Turnier, Jessica L. Fall, Ndate Thornton, Sherry Witte, David Bennett, Michael R. Appenzeller, Simone Klein-Gitelman, Marisa S. Grom, Alexei A. Brunner, Hermine I. |
author_facet | Turnier, Jessica L. Fall, Ndate Thornton, Sherry Witte, David Bennett, Michael R. Appenzeller, Simone Klein-Gitelman, Marisa S. Grom, Alexei A. Brunner, Hermine I. |
author_sort | Turnier, Jessica L. |
collection | PubMed |
description | BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease activity in childhood-onset systemic lupus erythematosus (cSLE). METHODS: In this multicenter study, S100 proteins were measured in the serum and urine of four cSLE cohorts and healthy control subjects using commercial enzyme-linked immunosorbent assays. Patients were divided into cohorts on the basis of biospecimen availability: (1) longitudinal serum, (2) longitudinal urine, (3) cross-sectional serum, and (4) cross-sectional urine. Global and renal disease activity were defined using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and the SLEDAI-2K renal domain score. Nonparametric testing was used for statistical analysis, including the Wilcoxon signed-rank test, Kruskal-Wallis test, Mann-Whitney U test, and Spearman’s rank correlation coefficient. RESULTS: All urine S100 proteins were elevated in patients with active LN compared with patients with active extrarenal disease and healthy control subjects. All urine S100 protein levels decreased with LN improvement, with S100A4 demonstrating the most significant decrease. Urine S100A4 levels were also higher with proliferative LN than with membranous LN. S100A4 staining in the kidney localized to mononuclear cells, podocytes, and distal tubular epithelial cells. Regardless of the S100 protein tested, serum levels did not change with cSLE improvement. CONCLUSIONS: Higher urine S100 levels are associated with increased LN activity in cSLE, whereas serum S100 levels do not correlate with disease activity. Urine S100A4 shows the most promise as an LN activity biomarker, given its pronounced decrease with LN improvement, isolated elevation in urine, and positive staining in resident renal cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1444-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5655804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56558042017-10-31 Urine S100 proteins as potential biomarkers of lupus nephritis activity Turnier, Jessica L. Fall, Ndate Thornton, Sherry Witte, David Bennett, Michael R. Appenzeller, Simone Klein-Gitelman, Marisa S. Grom, Alexei A. Brunner, Hermine I. Arthritis Res Ther Research Article BACKGROUND: Improved, noninvasive biomarkers are needed to accurately detect lupus nephritis (LN) activity. The purpose of this study was to evaluate five S100 proteins (S100A4, S100A6, S100A8/9, and S100A12) in both serum and urine as potential biomarkers of global and renal system-specific disease activity in childhood-onset systemic lupus erythematosus (cSLE). METHODS: In this multicenter study, S100 proteins were measured in the serum and urine of four cSLE cohorts and healthy control subjects using commercial enzyme-linked immunosorbent assays. Patients were divided into cohorts on the basis of biospecimen availability: (1) longitudinal serum, (2) longitudinal urine, (3) cross-sectional serum, and (4) cross-sectional urine. Global and renal disease activity were defined using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and the SLEDAI-2K renal domain score. Nonparametric testing was used for statistical analysis, including the Wilcoxon signed-rank test, Kruskal-Wallis test, Mann-Whitney U test, and Spearman’s rank correlation coefficient. RESULTS: All urine S100 proteins were elevated in patients with active LN compared with patients with active extrarenal disease and healthy control subjects. All urine S100 protein levels decreased with LN improvement, with S100A4 demonstrating the most significant decrease. Urine S100A4 levels were also higher with proliferative LN than with membranous LN. S100A4 staining in the kidney localized to mononuclear cells, podocytes, and distal tubular epithelial cells. Regardless of the S100 protein tested, serum levels did not change with cSLE improvement. CONCLUSIONS: Higher urine S100 levels are associated with increased LN activity in cSLE, whereas serum S100 levels do not correlate with disease activity. Urine S100A4 shows the most promise as an LN activity biomarker, given its pronounced decrease with LN improvement, isolated elevation in urine, and positive staining in resident renal cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1444-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-24 2017 /pmc/articles/PMC5655804/ /pubmed/29065913 http://dx.doi.org/10.1186/s13075-017-1444-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Turnier, Jessica L. Fall, Ndate Thornton, Sherry Witte, David Bennett, Michael R. Appenzeller, Simone Klein-Gitelman, Marisa S. Grom, Alexei A. Brunner, Hermine I. Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title | Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title_full | Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title_fullStr | Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title_full_unstemmed | Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title_short | Urine S100 proteins as potential biomarkers of lupus nephritis activity |
title_sort | urine s100 proteins as potential biomarkers of lupus nephritis activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655804/ https://www.ncbi.nlm.nih.gov/pubmed/29065913 http://dx.doi.org/10.1186/s13075-017-1444-4 |
work_keys_str_mv | AT turnierjessical urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT fallndate urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT thorntonsherry urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT wittedavid urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT bennettmichaelr urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT appenzellersimone urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT kleingitelmanmarisas urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT gromalexeia urines100proteinsaspotentialbiomarkersoflupusnephritisactivity AT brunnerherminei urines100proteinsaspotentialbiomarkersoflupusnephritisactivity |